Filing Details
- Accession Number:
- 0001104659-22-075786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-29 16:02:05
- Reporting Period:
- 2022-06-27
- Accepted Time:
- 2022-06-29 16:02:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689375 | Entrada Therapeutics Inc. | TRDA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1613084 | Dipal Doshi | C/O Entrada Therapeutics, Inc. 6 Tide Street Boston MA 02210 | President And Ceo | Yes | Yes | No | No |
Transaction Summary
Sold: | 4,000 shares | Avg. Price: $12.00 | Total Value: $48,000.00 |
Number of Shares After Transactions: | 210,710 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-27 | 4,000 | $12.00 | 210,710 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.